Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 2.145
+0.030 (1.42%)
Jul 6, 2026, 4:49 PM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 25.9 million as of July 6, 2026. Its market cap has increased by 19.72% in one year.
Market Cap
25.90M
Enterprise Value
41.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.15
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has decreased from 26.85M to 25.90M, a decrease of -3.54%. That is a compound annual growth rate of -0.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 25.90M | -10.93% |
| Dec 30, 2025 | 29.08M | -54.90% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 475.23M |
| Syn2bio | 427.90M |
| Ryvu Therapeutics | 350.50M |
| BIOTON | 340.88M |
| Synthaverse | 217.08M |
| Molecure | 124.44M |
| Mabion | 117.66M |
| Poltreg | 108.86M |